Find News

Filter articles

Showing 3541 to 3550 of 3632 results

Roche relinquishes patent on breast cancer drug


Drugmaker Roche has decided not to pursue a patent application for a breast cancer drug in the Indian market, enabling rivals to possibly produce cheaper versions.

Allergan sued over breast implant patent


Texas-based Almha has launched patent infringement lawsuits against four companies, including UK company Allergan, in relation to its patent covering a “breast implant with position lock”.

Sheppard Mullin hires partner in California


Lorna Tanner has joined the Palo Alto office of Sheppard Mullin Richter & Hampton LLP as an IP partner.

SIPO pulls Viread patent – victory for pharma innovators?


The Chinese State Intellectual Property Office (SIPO) has revoked a patent covering biopharmaceutical company Gilead Science’s HIV drug Viread, Reuters subsidiary news site BioWorld reported.

IPAB revokes Allergan eye drug patent

India12-08-2013Legal developments

On August 8 the IPAB revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.

Myriad patent suit enters antitrust territory


Ambry Genetics, the laboratory sued last month by biotech company Myriad over patents covering the BRCA1 and BRCA2 genes, has hit back with antitrust claims.

Indian patent office strikes down another blockbuster patent


The Kolkata Patent Office has refused divisional patents related to Swiss pharmaceutical company Roche’s breast cancer drug Herceptin.

Eversheds secures former Sidley Austin IP and life sciences head


Eversheds has appointed the former head of Sidley Austin's London IP and life sciences team Brett Rowland, as a partner.

Roche signs drug licensing agreement with MPP


On August 5, Swiss pharmaceutical company Roche signed an agreement with the MPP to increase access to its drug valganciclovir (Valcyte), an oral medicine for the treatment of preventable viral infection cytomegalovirus (CMV).

Section 3(d) strikes again in GSK India patent defeat


India’s Intellectual Property Appeal Board has revoked a patent covering GlaxoSmithKline’s breast cancer drug Tykerb, in the latest blow to western pharmaceutical companies in India.

Showing 3541 to 3550 of 3632 results